Priti Balchandani, PhD
img_Priti Balchandani
PROFESSOR | Diagnostic, Molecular and Interventional Radiology
PROFESSOR | Neuroscience
PROFESSOR | Psychiatry
Research Topics
Biomechanics/Bioengineering, Brain, Brain Imaging, Epilepsy, Imaging, MRI, Magnetic Resonance Imaging, Mathematical Modeling of Biomedical Systems, Neuroscience
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Novel MRI techniques to visualize the brain

Dr. Balchandani’s primary research goal is to develop anatomic, spectroscopic and functional magnetic resonance (MR) imaging tools to elucidate changes in brain structure, metabolism and function in the presence of disease. Her work is focused on the application of signal processing principles to the development of novel radio frequency (RF) pulses and pulse sequences that maximize the information imparted by MR images. She has developed several techniques to harness the power of high-field MR magnets by overcoming physical and hardware limitations in order to visualize the human brain in unprecedented structural and metabolic detail. In addition, she is interested in obtaining a direct window into neuronal activation and function by improving current functional imaging techniques and exploiting the MR signal of nuclei other than hydrogen. Together, these techniques are applied to improve diagnosis, treatment and monitoring of neurological diseases and disorders as well as advance our understanding of the brain in the normal state.

BASc, University of Waterloo

MS, Stanford University

PhD, Stanford University


NIH Research Project Grant (R01)New award

National Institute of Mental Health


NIH Research Project Grant (R01)

National Cancer Institute


NIH Research Project Grant (R01)

National Institute of Mental Health


NIH Small Business Technology Transfer (STTR)

National Institute of Biomedical Imaging and Bioengineering


NIH Pathway to Independence Award

National Institute of Neurological Disorders and Stroke


Named Junior Fellow of International Society for Magnetic Resonance in Medicine (ISMRM)


Young Investigators’ Award Finalist at ISMRM

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Balchandani during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • RefleXion Medical

Royalty Payments:

  • GE HealthCare; Siemens
  • GE HealthCare; Philips Healthcare; Siemens

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.